Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jasmeen Oberoi

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The Journal of Biological Chemistry|October 1, 2010
Structural basis of poly(ADP-ribose) recognition by the multizinc binding domain of checkpoint with forkhead-associated and RING Domains (CHFR)Jasmeen Oberoi, Mark W Richards, Simon Crumpler, et al.
Sub-Cellular Biochemistry|December 15, 2022
HSP70-HSP90 Chaperone Networking in Protein-Misfolding DiseaseChrisostomos Prodromou, Xavi Aran-Guiu, Jasmeen Oberoi, et al.
Cell Stress & Chaperones|December 5, 2025
The dihydropyridine LA1011 modulates multiple Hsp90-co-chaperone interactions relevant to Alzheimer's diseaseXavier Jeanne, Jasmeen Oberoi, Mark S Roe, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 29, 2016
Structural and functional basis of protein phosphatase 5 substrate specificityJasmeen Oberoi, Diana M Dunn, Mark R Woodford, et al.
Biomolecules|July 27, 2022
Recognition of BRAF by CDC37 and Re-Evaluation of the Activation Mechanism for the Class 2 BRAF-L597R MutantDennis M Bjorklund, R Marc L Morgan, Jasmeen Oberoi, et al.
Nature Communications|November 29, 2022
HSP90-CDC37-PP5 forms a structural platform for kinase dephosphorylationJasmeen Oberoi, Xavi Aran Guiu, Emily A Outwin, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2022
Time to diagnosis and treatment of lung cancer: A systematic overview of risk factors, interventions and impact on patient outcomesJianrong Zhang, Maarten J IJzerman, Jasmeen Oberoi, et al.
Patient Education and Counseling|August 17, 2021
Informed choice and attitudes regarding a genomic test to predict risk of colorectal cancer in general practiceSibel Saya, Jennifer G McIntosh, Ingrid M Winship, et al.
Public Health Genomics|July 21, 2020
A Genomic Test for Colorectal Cancer Risk: Is This Acceptable and Feasible in Primary Care?Sibel Saya, Jennifer G McIntosh, Ingrid M Winship, et al.
Advances in Therapy|April 28, 2021
Identifying Novel Biomarkers Ready for Evaluation in Low-Prevalence Populations for the Early Detection of Lower Gastrointestinal Cancers: A Systematic Review and Meta-AnalysisPaige Druce, Natalia Calanzani, Claudia Snudden, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Journal of Biological Chemistry|October 1, 2010
Structural basis of poly(ADP-ribose) recognition by the multizinc binding domain of checkpoint with forkhead-associated and RING Domains (CHFR)Jasmeen Oberoi, Mark W Richards, Simon Crumpler, et al.
Sub-Cellular Biochemistry|December 15, 2022
HSP70-HSP90 Chaperone Networking in Protein-Misfolding DiseaseChrisostomos Prodromou, Xavi Aran-Guiu, Jasmeen Oberoi, et al.
Cell Stress & Chaperones|December 5, 2025
The dihydropyridine LA1011 modulates multiple Hsp90-co-chaperone interactions relevant to Alzheimer's diseaseXavier Jeanne, Jasmeen Oberoi, Mark S Roe, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 29, 2016
Structural and functional basis of protein phosphatase 5 substrate specificityJasmeen Oberoi, Diana M Dunn, Mark R Woodford, et al.
Biomolecules|July 27, 2022
Recognition of BRAF by CDC37 and Re-Evaluation of the Activation Mechanism for the Class 2 BRAF-L597R MutantDennis M Bjorklund, R Marc L Morgan, Jasmeen Oberoi, et al.
Nature Communications|November 29, 2022
HSP90-CDC37-PP5 forms a structural platform for kinase dephosphorylationJasmeen Oberoi, Xavi Aran Guiu, Emily A Outwin, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2022
Time to diagnosis and treatment of lung cancer: A systematic overview of risk factors, interventions and impact on patient outcomesJianrong Zhang, Maarten J IJzerman, Jasmeen Oberoi, et al.
Patient Education and Counseling|August 17, 2021
Informed choice and attitudes regarding a genomic test to predict risk of colorectal cancer in general practiceSibel Saya, Jennifer G McIntosh, Ingrid M Winship, et al.
Public Health Genomics|July 21, 2020
A Genomic Test for Colorectal Cancer Risk: Is This Acceptable and Feasible in Primary Care?Sibel Saya, Jennifer G McIntosh, Ingrid M Winship, et al.
Advances in Therapy|April 28, 2021
Identifying Novel Biomarkers Ready for Evaluation in Low-Prevalence Populations for the Early Detection of Lower Gastrointestinal Cancers: A Systematic Review and Meta-AnalysisPaige Druce, Natalia Calanzani, Claudia Snudden, et al.
Pageof 2